Clinical Trials Directory

Trials / Completed

CompletedNCT06948630

Hemogram Parameter Changes With Sepsis Filter

Change in Hemogram-Derived Ratios With Sepsis Filters:A Retrospective Cohort Study in the Intensive Care Unit

Status
Completed
Phase
Study type
Observational
Enrollment
92 (actual)
Sponsor
Samsun University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Hemodiafiltration is initiated in hemodynamically unstable patients in intensive care units. In some patients, additional devices called cytokine filters or sepsis filters are added to remove inflammatory cytokines. Data obtained from hemograms, such as platelet lymphocytosis ratio, are used in the diagnosis or prognosis of many diseases. This study focuses on the change in hemogram rates in patients who received hemofiltration and sepsis filters.

Conditions

Timeline

Start date
2024-01-01
Primary completion
2024-02-01
Completion
2024-02-01
First posted
2025-04-29
Last updated
2025-04-29

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06948630. Inclusion in this directory is not an endorsement.

Hemogram Parameter Changes With Sepsis Filter (NCT06948630) · Clinical Trials Directory